Skip to main content
. 2024 Jan 29;31(2):86–96. doi: 10.4078/jrd.2023.0045

Figure 1.

Figure 1

Patient disposition. Anti-TNF: anti-tumor necrosis factor agent, cDMARD: conventional disease-modifying anti-rheumatic drug, FAS: full analysis set, PPS: per-protocol set.